Primary Site >> Liver Cancer
Gene >> HBE1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Incidence and clinical significance of HBe antigen and antibody in HBsAg-positive various liver diseases. PMID: 230994 |
Ref: Immunological and anti-viral therapy of chronic hepatitis B virus infection. PMID: 6156790 |
Ref: Hepatitis Be antigen and antibody in chronic liver diseases and hepatocellular carcinoma. PMID: 6284625 Ref: The HBe antigen-antibody system and its relationship to clinical and laboratory findings in 100 chronic HBsAg carriers in Great Britain. PMID: 7328422 |
Ref: Detection of hepatitis B virus DNA directly in human serum by a simplified molecular hybridization test: comparison to HBeAg/anti-HBe status in HBsAg carriers. PMID: 6301965 Ref: [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases]. PMID: 6840666 |
Ref: Analysis of the molecular state of HBV-DNA in the liver and serum of patients with chronic hepatitis or primary liver cell carcinoma and the effect of therapy with adenine arabinoside. PMID: 6203813 |
Ref: Detection of serum HBV-DNA by molecular hybridisation. Correlation with HBeAg/anti-HBe status, racial origin, liver histology and hepatocellular carcinoma. PMID: 2997321 Ref: Need for hepatocellular carcinoma screening before renal transplantation in HBs +, HBe +, western African. PMID: 2998662 |
Ref: Persistence of circulating complexes between HBsAg and immunoglobulin M in sera of hepatitis B surface antigen positive patients suffering from liver cirrhosis or primary liver cancer. PMID: 3943106 |
Ref: Low incidence and high titers of antibodies to hepatitis B virus X-protein in sera of Chinese patients with hepatocellular carcinoma. PMID: 2844980 |
Ref: Studies of clinically latent cirrhosis. PMID: 1964671 Ref: The hepatitis B virus. PMID: 2149522 |
Ref: [Pre S2: a marker for chronicity and/or liver damage in hepatitis B infection?]. PMID: 1340959 |
Ref: Chronic hepatitis B infection in Malaysians. PMID: 16329567 |
Ref: The significance of spontaneous hepatitis B e antigen seroconversion in childhood: with special emphasis on the clearance of hepatitis B e antigen before 3 years of age. PMID: 7590652 Ref: [Pathogenetic role of HBV in liver cell carcinoma of Western European patients]. PMID: 8600676 |
Ref: [Drug therapy of chronic hepatitis B]. PMID: 9833259 |
Ref: Immunological characterization of two major secreted forms of recombinant hepatitis B virus e antigens. PMID: 10082391 Ref: Immunohistochemical study of HBV antigens in 338 liver cell carcinomas. PMID: 10413841 Ref: Clinical implications of mutations C-to-T1653 and T-to-C/A/G1753 of hepatitis B virus genotype C genome in chronic liver disease. PMID: 10481738 Ref: [Prevalence of HCV and HBV infection in patients with primary hepatocellular carcinoma in Shanxi Province]. PMID: 10682498 Ref: [Association between Class I HLA alleles and HBs antigen carrier status among blood donors in Senegal]. PMID: 11957279 |
Ref: Natural history of chronic hepatitis B virus infection. PMID: 10921377 Ref: Hepatitis B virus X gene variability in French-born patients with chronic hepatitis and hepatocellular carcinoma. PMID: 11002246 |
Ref: Transcription-mediated amplification is more useful in the follow-up of patients with chronic hepatitis B treated with lamivudine. PMID: 11470630 Ref: Treatment of chronic hepatitis B: interferon alfa first. PMID: 11503853 |
Ref: A case of complete necrosis of well-differentiated early hepatocellular carcinoma by percutaneous transhepatic portal embolization. PMID: 11804837 |
Ref: Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease. PMID: 12500184 Ref: [Therapy of viral hepatitis]. PMID: 14610905 Ref: New aspects on the natural history of chronic hepatitis B infection: implication for therapy. PMID: 14723354 |
Ref: Efficacy of intramuscular matrine in the treatment of chronic hepatitis B. PMID: 14969841 Ref: Four years of treatment with lamivudine: clinical and virological evaluations in HBe antigen-negative chronic hepatitis B. PMID: 15274664 Ref: Prophylactic lamivudine administration prevents exacerbation of liver damage in HBe antigen positive patients with hepatocellular carcinoma undergoing transhepatic arterial infusion chemotherapy. PMID: 15571585 |
Ref: Favorable efficacy of long-term lamivudine therapy in patients with chronic hepatitis B: an 8-year follow-up study. PMID: 15714490 Ref: Hepatitis B Virus e Antigen Variants. PMID: 15968333 Ref: Effects of HBV gene variations on disease development and antiviral therapy for patients with chronic hepatitis B. PMID: 16109523 |
Ref: Molecular and serological characterization of hepatitis B virus in deferred Ghanaian blood donors with and without elevated alanine aminotransferase. PMID: 17052270 |
Ref: Antiviral therapy and resistance with hepatitis B virus infection. PMID: 17206760 Ref: Best practice in the treatment of chronic hepatitis B: a summary of the European Viral Hepatitis Educational Initiative (EVHEI). PMID: 17697725 Ref: Chronic hepatitis B: a wider range of therapeutic options. PMID: 17724844 Ref: Comparison of complete sequences of hepatitis B virus genotype C between inactive carriers and hepatocellular carcinoma patients before and after seroconversion. PMID: 17940837 |
Ref: Long-term outcome of hepatitis B and hepatitis C virus co-infection and single HBV infection acquired in youth. PMID: 19856471 |
Ref: [Hepatitis B vaccination: a major player in the control of primary liver cancer]. PMID: 19896296 Ref: [Chronic hepatitis B: antiviral treatment guidelines]. PMID: 20623887 |
Ref: A population-based cohort study for the risk factors of HCC among hepatitis B virus mono-infected subjects in Japan. PMID: 20820820 Ref: [Natural history of viral hepatitis]. PMID: 21452540 Ref: Ultrasensitive quantification of hepatitis B virus A1762T/G1764A mutant by a SimpleProbe PCR using a wild-type-selective PCR blocker and a primer-blocker-probe partial-overlap approach. PMID: 21562108 Ref: The prevalence of HBV infection in the cohort of IDPs of war against terrorism in Malakand Division of Northern Pakistan. PMID: 21689435 Ref: HBV-carriers: When is monitoring and surveillance sufficient? (point of view). PMID: 21821479 Ref: Angiographic-CT-FDG-Pathologic Correlations of the Incidentally Discovered Adrenal Mass. PMID: 22315709 |
Ref: Hepatitis B virus DNA in patients with HBsAg in south western Nigeria. PMID: 23161583 Ref: Predominance of precore mutations and clinical significance of basal core promoter mutations in chronic hepatitis B virus infection in Indonesia. PMID: 24648979 Ref: PMID: 25473721 |
Ref: Therapeutic management and evolution of chronic hepatitis B: does HIV still have an impact? The EPIB 2012 study. PMID: 25559645 Ref: Current and future directions for treating hepatitis B virus infection. PMID: 26085913 |
Ref: Oncogenic circuit constituted by Ser31-HBx and Akt increases risks of chronic hepatitis and hepatocellular carcinoma. PMID: 26791804 Ref: Comparison of Demographic and Clinical Characteristics of Hispanic and Asian Chronic Hepatitis B Patients in Southern California. PMID: 26890328 Ref: A predictive model for carcinogenesis in patients with chronic hepatitis B undergoing entecavir therapy and its validation. PMID: 27603400 |
Ref: Persistent phosphorylation at specific H3 serine residues involved in chemical carcinogen-induced cell transformation. PMID: 27996159 Ref: Characteristics and course of chronic hepatitis B e antigen-negative infection. PMID: 28007350 Ref: Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis PMID: 28404133 |